Children's heartburn drug trial halted early – but data may still help
NCT ID NCT02615184
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a daily medicine called dexlansoprazole to heal and prevent return of erosive esophagitis (damage to the esophagus from stomach acid) in children aged 2 to 11 years. The trial was stopped early, but researchers aimed to see if the drug could heal the esophagus within 8 weeks and keep it healed for up to 24 weeks. Participants took the medicine or a placebo, and reported symptoms like heartburn and stomach pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EROSIVE ESOPHAGITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boca Clinical Trials Mexico SC
Colonia Las Americas, Mexico City, 1120, Mexico
-
Centro Medico Imbanaco de Cali S.A
Cali, 760042, Colombia
-
Children's Center for Digestive Health Care, LLC
Atlanta, Georgia, 30342, United States
-
Clinical Research Institute S.C.
Tlalnepantla, State of Mexico, 54055, Mexico
-
D&H National Research Centers
Miami, Florida, 33155, United States
-
El Cielo Medical Center
Puebla City, 72160, Mexico
-
Envision Clinical Research, LLC
Laredo, Texas, 78041, United States
-
Fundacion Valle del Lili
Cali, 760032, Colombia
-
GI for Kids
Knoxville, Tennessee, 37922, United States
-
Gabinet Lekarski Bartosz Korczowski
Rzeszów, Podkarpackie Voivodeship, 35-302, Poland
-
Gastrointestinal Associates, PA
Flowood, Mississippi, 39232, United States
-
Hospital Universitario San Ignacio
Bogotá, 110231, Colombia
-
In Vivo Osrodek Badan Klinicznych
Bydgoszcz, Kuyavia, 85-048, Poland
-
Inspirepharma S. de R.L. de C.V.
Monterrey, Nuevo León, 64660, Mexico
-
Instytut "Pomnik - Centrum Zdrowia Dziecka"
Warsaw, Masovia, 04-730, Poland
-
London Health Sciences Centre (LHSC) - Children's Hospital
London, Ontario, N6A 5W9, Canada
-
Measurable Outcome Research
Oklahoma City, Oklahoma, 73112, United States
-
SMIQ S. de R.L. de C.V.
Querétaro, 76070, Mexico
-
The Children's Hospital of The King's Daughters
Norfolk, Virginia, 23507, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of California San Francisco
San Francisco, California, 94158, United States
-
University of South Alabama
Mobile, Alabama, 36604, United States
-
Uniwersytecki Szpital Dzieciecy w Krakowie
Krakow, Lesser Poland Voivodeship, 30-663, Poland
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
-
Women and Children's Health Research Institute
Edmonton, Alberta, T6G 1C9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill prevent esophageal damage from returning?
- Smart bottle cap could reveal hidden missed doses in GERD patients
- New GERD drug aims to heal esophagus damage when standard treatments fail
- Children's heartburn drug study halted early
- New GERD drug aims to keep esophagus healed, but trial never started
- New pill aims to heal Acid-Damaged esophagus